Double-blind, placebo-controlled study for the effects of the extract from roasted chicory root on lipid metabolism.

Double-blind, placebo-controlled study for the effects of the extract from roasted chicory root on lipid metabolism. - Effects of the extract from roasted chicory root on lipid metabolism.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015908

Enrollment

Registered

2014-12-10

Start date

2013-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia

Interventions

Ingesting 300 ml of the effects of roasted chicory root daily for 4 weeks. Ingesting 300 ml of barley tea containing 10% coffee (placebo) for 4 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Subjects who agree to participate in the current study with a written informed consent.

Exclusion criteria

Exclusion criteria: (1)Subjects who are under medication for chronic ailments. (2) Subjects with serious diseases and infections. (3) Subjects with clinical history of gastrointestinal surgery. (4) Subjects having a family history of hypercholesterolemia (5) Subjects with frequent complaints of post-menopausal symptoms. (6) Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. (7) Subjects with serious anemia. (8) Subjects with a history of allergy to medicine and food, especially dairy products. (9) Subjects routinely on supplementation which would affect the lipid metabolism. (10) Heavy smokers and alcohol addicts, or subjects with irregular lifestyle. (11) Subjects who donate 400ml whole blood within 12 weeks or who donate plasma or platelets within 4 weeks prior to supplementation. (12) Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. (13) Subjects who participate in other clinical trials within the last one month prior to the current clinical trial. (14) Subjects who are not eligible due to physician's judgment.

Design outcomes

Primary

Measure	Time frame
LDL-Cho,serum adiponectin	—

Secondary

Measure	Time frame
Lipid metabolism (T-cho, TG, HDL-cho), blood glucose (FBG, HbA1c, Insulin), VAS questionnaire (defecation frequency etc.) , Body composition (weight, BMI, fat percentage)	—

Countries

Japan

Contacts

Public ContactDir. Prof. Jun Nishihira, M.D.

Hokkaido Information University Health Information Science Center

nishihira@do-johodai.ac.jp011-385-4430

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026